MAAT
maatapp.com
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Haatch
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
App Store
4.5 ★
14 ratings
Backed byfrom the funds' portfolios and accelerator catalogs
Haatch Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Gymdesk is a web based management software platform designed for gyms and martial arts schools. It offers tools for membership management…
Automate payments, sell memberships & manage clients. The must-have app for independent PTs, yoga, dance & martial arts instructors. Free…
Streamline your business with Approach, the top climbing gym management software. Elevate your gym with climbing gym software designed to…
Run your gym with effortless management, powerful automation, and a beautiful member app. Simplify operations and grow your community with…
All-in-one gym management software built to simplify operations, boost member engagement, and grow your fitness business.
Togetherhood is an after-school enrichment company headquartered in New York that connects schools, residential buildings and communities…
News
MaaT Pharma Announces Upcoming Pre-IND Meeting with the FDA and Advances MaaT034 Toward Clinical Development in Solid Tumors
Read more
Report
MaaT Pharma Secures €37.5 Million Loan From European Investment Bank (EIB) Marking a New Step in Advancing its Clinical Program in Hemato-Oncology
LYON, France, July 28, 2025--MaaT Pharma Secures €37.5 Million Loan From European Investment Bank (EIB) Marking a New Step in Advancing its Clinical Program in Oncology
Read more
Report
MaaT Pharma Secures €37.5 Million Loan From European Investment Bank (EIB) Marking a New Step in Advancing its Clinical Program in Hemato-Oncology
MaaT Pharma Secures €37.5 Million Loan From European Investment Bank (EIB) Marking a New Step in Advancing its Clinical Program in Oncology
Read more
Report
Report
MaaT Pharma, Leader in Development of Microbiome-Based Therapies in Oncology, Awarded Government Funding for Clinical Development of MaaT033 as part of the France 2030 Plan
Read more
Report
MaaT Pharma Joins Microbiome Therapeutics Innovation Group
/PRNewswire/ -- The Microbiome Therapeutics Innovation Group (MTIG) today announced the addition of MaaT Pharma to its coalition of companies leading the...
Read more
Report
Report
Show more news